Plasma p-tau217 successfully identified Alzheimer's pathology in several neurodegenerative syndromes. This included disorders not typically associated with Alzheimer's disease, like frontotemporal ...

Please provide your email address to receive an email when new articles are posted on . The AD2 blood test was roughly 90% accurate at Alzheimer’s identification. Diagnoses of subjective cognitive ...

Please provide your email address to receive an email when new articles are posted on . A new blood test may be able to detect Alzheimer’s disease-related pathology up to 10 years before symptoms ...

Findings showed testing with Elecsys pTau181 helped to rule out Alzheimer pathology with a 97.9% negative predictive value in this early disease-stage population. The Food and Drug Administration (FDA ...

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test can detect small amounts of the clumping-prone tau protein and its misfolded pathological forms ...

ST. LOUIS--(BUSINESS WIRE)--C2N Diagnostics, LLC (C2N), a world leader in developing Alzheimer’s disease-specific fluid biomarker tests, has received a new $15 million program-related investment from ...

SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, a privately held biotech company advancing innovative cancer diagnostics, announced that Precision Pathology Services, a CAP/CLIA-certified ...

Sixto M. Leal Jr., M.D., Ph.D., Jay M. McDonald Endowed Professor in Experimental Pathology and Division Director, Laboratory Medicine, has been appointed to the American Board of Pathology's (ABPath) ...

Congratulations to Marisa Marques, M.D., Professor, Laboratory Medicine, who has accepted a nomination to join the American Board of Pathology (ABPath) Test Development and Advisory Committee for ...

The Australian Digital Health Agency (ADHA), the system administrator for My Health Record, has touted an increase in use of the online medical file in the past few months. "We've seen a significant ...